Bacterial membrane proteins and enzymes

Bacterial membrane proteins and enzymes constitute a diverse group of molecules essential for the survival, structural integrity, and pathogenesis of bacteria (EcoSal Plus, 2015). This category includes penicillin-binding proteins (PBPs) that catalyze the final steps of peptidoglycan synthesis, as well as various transporters and efflux pumps that regulate the internal environment (StatPearls, 2023; Nature Reviews Microbiology, 2021). These proteins are often located in the cytoplasmic membrane or the outer membrane of Gram-negative bacteria, making them highly accessible targets for antimicrobial therapy (Frontiers in Microbiology, 2019). Drugs such as beta-lactams inhibit cell wall-synthesizing enzymes, while polymyxins and lipopeptides like daptomycin disrupt the physical integrity of the membrane itself (NCBI, 2019; PubMed, 2020). Because many of these targets are unique to prokaryotes, they offer a high degree of selectivity, minimizing cross-reactivity with human host cells (Journal of Biological Chemistry, 2022). However, the clinical utility of targeting these proteins is frequently undermined by the development of resistance, including mutations that alter target binding sites or the upregulation of efflux systems (WHO, 2021). Understanding the functional landscape of these membrane-associated components is critical for the development of next-generation antibiotics to combat multi-drug resistant infections (Clinical Microbiology Reviews, 2018).

Other names

Bacterial cell envelope proteinsBacterial surface proteinsBacterial membrane-associated enzymesProkaryotic membrane proteins

Inhibition of peptidoglycan biosynthesis through binding to penicillin-binding proteins, disruption of bacterial membrane potential and permeability, and inhibition of membrane-bound metabolic enzymes.